Fresenius | FRE - Debt


Fresenius reported EUR11.93B in Debt for its fiscal quarter ending in December of 2025.





Debt Change Date
Akzo Nobel EUR 4.86B 984M Dec/2025
Alcon AG USD 5.25B 4.74B Mar/2026
AstraZeneca USD 33.92B 4.3B Mar/2026
BASF EUR 23.21B 442M Dec/2025
Bayer EUR 36.45B 2.93B Dec/2025
Beiersdorf EUR 100M 252M Dec/2025
DaVita Healthcare Partners USD 13.22B 346.51M Mar/2026
Demant DKK 20.99B 4.81B Dec/2025
E.ON EUR 40.1B 1.04B Mar/2025
Essilor EUR 14.4B 348M Dec/2025
Fresenius EUR 11.93B 919M Dec/2025
Fresenius Medical Care EUR 11.03B 233.8M Mar/2026
Getinge SEK 10.73B 141M Dec/2024
Givaudan CHF 5.32B 416M Jun/2024
GlaxoSmithKline GBP 19.06B 1.34B Mar/2026
GN Store Nord DKK 10.82B 971M Dec/2025
GRIFOLS EUR 9.57B 746.56M Dec/2025
Hikma Pharmaceutical USD 1.56B 252M Jun/2025
Lonza CHF 4.71B 915M Dec/2024
Merck EUR 11.95B 152M Dec/2025
Novartis USD 47B 11.62B Mar/2026
Philips EUR 7.81B 574M Dec/2025
Roche Holding CHF 33.03B 1.41B Jun/2025
RWE EUR 17.01B 3.07B Dec/2025
Sanofi EUR 20.33B 1.43B Dec/2025
Smith & Nephew USD 3.32B 334M Dec/2024